Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD.

Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9649-53.

2.

Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.

Vidal R, Calero M, Piccardo P, Farlow MR, Unverzagt FW, Méndez E, Jiménez-Huete A, Beavis R, Gallo G, Gomez-Tortosa E, Ghiso J, Hyman BT, Frangione B, Ghetti B.

Acta Neuropathol. 2000 Jul;100(1):1-12.

PMID:
10912914
3.
4.

Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.

Heinonen O, Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Sorvari H, Kosunen O, Paljärvi L, Ryynänen M, Riekkinen PJ Sr.

Neurobiol Aging. 1995 Jul-Aug;16(4):505-13.

PMID:
8544899
5.
6.

Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.

McNamara MJ, Gomez-Isla T, Hyman BT.

Arch Neurol. 1998 Jul;55(7):1001-4.

PMID:
9678319
7.

Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.

Attems J, Lintner F, Jellinger KA.

Acta Neuropathol. 2004 Apr;107(4):283-91. Epub 2004 Feb 20. Erratum in: Acta Neuropathol (Berl). 2004 May;107(5):479-80.

PMID:
14986026
8.

Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ.

Neurobiol Dis. 1996 Feb;3(1):16-32.

PMID:
9173910
9.

Association of human, rat, and rabbit apolipoprotein E with beta-amyloid.

LaDu MJ, Lukens JR, Reardon CA, Getz GS.

J Neurosci Res. 1997 Jul 1;49(1):9-18.

PMID:
9211985
10.
11.

ApoE epsilon3-haplotype modulates Alzheimer beta-amyloid deposition in the brain.

Myllykangas L, Polvikoski T, Reunanen K, Wavrant-De Vrieze F, Ellis C, Hernandez D, Sulkava R, Kontula K, Verkkoniemi A, Notkola IL, Hardy J, Perez-Tur J, Haltia MJ, Tienari PJ.

Am J Med Genet. 2002 Apr 8;114(3):288-91.

PMID:
11920850
12.

Cerebral amyloid angiopathy and dementia.

Tian J, Shi J, Mann DM.

Panminerva Med. 2004 Dec;46(4):253-64. Review.

PMID:
15876981
13.

Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.

Beffert U, Cohn JS, Petit-Turcotte C, Tremblay M, Aumont N, Ramassamy C, Davignon J, Poirier J.

Brain Res. 1999 Oct 2;843(1-2):87-94.

PMID:
10528114
15.
16.

Two types of sporadic cerebral amyloid angiopathy.

Thal DR, Ghebremedhin E, Rüb U, Yamaguchi H, Del Tredici K, Braak H.

J Neuropathol Exp Neurol. 2002 Mar;61(3):282-93.

PMID:
11895043
17.
18.

Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.

Poirier J.

Ann N Y Acad Sci. 2000;924:81-90. Review.

PMID:
11193807
19.

Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer's disease.

Tomiyama T, Corder EH, Mori H.

Cell Mol Life Sci. 1999 Oct 15;56(3-4):268-79. Review.

PMID:
11212354
20.

Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.

Tanskanen M, Lindsberg PJ, Tienari PJ, Polvikoski T, Sulkava R, Verkkoniemi A, Rastas S, Paetau A, Kiuru-Enari S.

Neuropathol Appl Neurobiol. 2005 Dec;31(6):589-99.

PMID:
16281907

Supplemental Content

Support Center